ARDTNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Ardent Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$11.69−0.26 (-2.18%)
Close on Oct 19, 2026
- Market cap
- $1.67B
- P/E (TTM)
- 21.3
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
76.9%
108M of 141M shares
Institutional holders
139
23 new, 19 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
2 buys · 0 sales
Net bought $186.40K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Ventas, Inc. | 9,342,501 | 6.55% | 13G (passive) | Jul 17, 2024 |
| Chai Trust Company, LLC | 77,246,499 | 54.10% | 13G (passive) | Sep 30, 2024 |
| Pure Health Capital Americas 1 SPV RSC LTD (1) | 30,262,664 | 21.20% | 13G (passive) | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ARDT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Chai Trust Co LLC | 77,246,499 | 54.77% | $760.11M | – | 52.26% |
| Ventas, Inc. | 9,342,501 | 6.62% | $91.93M | – | 100.00% |
| BlackRock, Inc. | 2,176,348 | 1.54% | $21.42M | +418,133 | 0.00% |
| Ameriprise Financial Inc | 2,110,599 | 1.50% | $20.77M | +333,873 | 0.00% |
| Goldentree Asset Management LP | 1,580,423 | 1.12% | $15.53M | −722,690 | 0.90% |
| Aqr Capital Management LLC | 1,447,810 | 1.03% | $14.25M | +505,457 | 0.00% |
| CastleKnight Management LP | 1,076,967 | 0.76% | $10.60M | – | 0.14% |
| Vanguard Capital Management LLC | 963,833 | 0.68% | $9.48M | −44,605 | 0.00% |
| Bridgeway Capital Management, LLC | 841,126 | 0.60% | $8.28M | −89,542 | 0.15% |
| Geode Capital Management, LLC | 620,947 | 0.44% | $6.11M | +59,504 | 0.00% |
| Algert Global LLC | 597,745 | 0.42% | $5.88M | +554,345 | 0.07% |
| State Street Corp | 566,205 | 0.40% | $5.57M | −19,853 | 0.00% |
| First Trust Advisors LP | 562,278 | 0.40% | $5.53M | +83,483 | 0.00% |
| Empowered Funds, LLC | 551,293 | 0.39% | $5.42M | +15,458 | 0.03% |
| SageView Advisory Group, LLC | 480,447 | 0.34% | $4.73M | −160,149 | 0.15% |
| Hotchkis & Wiley Capital Management LLC | 444,896 | 0.32% | $4.38M | +2,300 | 0.01% |
| UBS Group AG | 442,619 | 0.31% | $4.36M | −8,061 | 0.00% |
| Bank Of America Corp /De/ | 390,241 | 0.28% | $3.84M | +29,203 | 0.00% |
| Wedge Capital Management L L P/Nc | 327,242 | 0.23% | $3.22M | +222,447 | 0.05% |
| Morgan Stanley | 315,960 | 0.22% | $3.11M | +23,929 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 139 | 108M | 76.9% | 23 / 67 | 35 / 19 | 4M | 3M |
| Q1 2026 | 137 | 107M | 75.8% | 32 / 50 | 37 / 19 | 5M | 3M |
| Q4 2025 | 127 | 107M | 75.5% | 34 / 37 | 44 / 30 | 5M | 5M |
| Q3 2025 | 123 | 107M | 75.8% | 36 / 53 | 25 / 23 | 14M | 3M |
| Q2 2025 | 110 | 95M | 67.4% | 21 / 48 | 31 / 19 | 3M | 3M |
| Q1 2025 | 108 | 94M | 67.0% | 39 / 44 | 19 / 18 | 7M | 5M |
| Q4 2024 | 89 | 103M | 72.9% | 28 / 33 | 15 / 12 | 12M | 2M |
| Q3 2024 | 73 | 93M | 65.8% | 73 / 0 | 0 / 0 | 93M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ARDT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Columbia Small Cap Value Discovery Fund | 1,028,221 | 0.73% | $10.97M | 0.44% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 661,990 | 0.47% | $6.51M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 644,482 | 0.46% | $6.34M | 0.01% | Jun 30, 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 551,293 | 0.39% | $5.42M | 0.23% | Jun 30, 2026 |
| Columbia Small Cap Value and Inflection Fund | 452,380 | 0.32% | $4.18M | 0.48% | May 31, 2026 |
| First Trust Small Cap Core AlphaDEX Fund | 443,260 | 0.31% | $4.73M | 0.35% | Jul 31, 2026 |
| Omni Small-Cap Value Fund | 289,833 | 0.21% | $2.85M | 0.22% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 271,704 | 0.19% | $2.67M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 259,189 | 0.18% | $2.77M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 230,800 | 0.16% | $2.27M | 0.02% | Jun 30, 2026 |
| Columbia Variable Portfolio - Small Cap Value Discovery Fund | 185,951 | 0.13% | $1.83M | 0.41% | Jun 30, 2026 |
| WisdomTree U.S. SmallCap Fund | 170,484 | 0.12% | $1.68M | 0.23% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 130,622 | 0.09% | $1.21M | 0.00% | May 31, 2026 |
| Hotchkis and Wiley Small Cap Diversified Value Fund | 124,000 | 0.09% | $1.22M | 0.13% | Jun 30, 2026 |
| First Trust Small Cap Value AlphaDEX Fund | 121,445 | 0.09% | $1.30M | 0.67% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Dave Caspers | CEO and President, Director | 174,930 | 0.12% | Jul 2, 2026 |
| Martin Bonick | President and CEO, Director | 1,437,937 | 1.02% | Apr 2, 2026 |
| Stephen C. Petrovich | EVP, GC and Secretary | 960,144 | 0.68% | Sep 29, 2026 |
| David Raynor Byers | SVP & Chief Accounting Officer | 129,921 | 0.09% | Sep 29, 2026 |
| Alfred Lumsdaine | Chief Financial Officer | 325,794 | 0.23% | Sep 29, 2026 |
| Ethan Chernin | President of Health Services | 68,396 | 0.05% | Mar 13, 2026 |
| David Schultz | President Hospital Operations | 64,172 | 0.05% | Apr 2, 2025 |
| Robert DeMichiei | Director | 35,564 | 0.03% | Jun 8, 2026 |
| Peter J. Bulgarelli | Director | 14,231 | 0.01% | Apr 2, 2026 |
| Robert Thomas Webb | Director | 78,215 | 0.06% | Apr 2, 2026 |
| Peter C. B. Bynoe | Director | 115,367 | 0.08% | Apr 2, 2026 |
| Rahul Sen | Director | 38,709 | 0.03% | Apr 2, 2026 |
| Suzanne Campion | Director | 58,215 | 0.04% | Apr 2, 2026 |
| Edmondo Robinson | Director | 58,215 | 0.04% | Apr 2, 2026 |
| Ellen Havdala | Director | 115,367 | 0.08% | Apr 2, 2026 |
| Mark R. Sotir | Director | 38,709 | 0.03% | Apr 2, 2026 |
| William M. Goodyear | Director | 115,367 | 0.08% | Apr 2, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Stephen C. Petrovich EVP, GC and Secretary | Sep 25, 2026 | Tax withholding | −788 | $10.54 | $8.31K | 773,919 |
| Alfred Lumsdaine Chief Financial Officer | Sep 25, 2026 | Tax withholding | −3,389 | $10.54 | $35.72K | 325,794 |
| David Raynor Byers SVP & Chief Accounting Officer | Sep 25, 2026 | Tax withholding | −524 | $10.54 | $5.52K | 129,921 |
| Dave Caspers CEO and President, Director | Jul 1, 2026 | Award | +103,653 | – | – | 174,930 |
| Robert DeMichiei Director | Jun 5, 2026 | Buy | +11,260 | $8.73 | $98.30K | 35,564 |
| Alfred Lumsdaine Chief Financial Officer | Jun 5, 2026 | Buy | +10,000 | $8.81 | $88.10K | 329,183 |
| Peter J. Bulgarelli Director | Apr 1, 2026 | Award | +14,231 | – | – | 14,231 |
| Rahul Sen Director | Apr 1, 2026 | Award | +14,231 | – | – | 38,709 |
| Martin Bonick President and CEO, Director | Apr 1, 2026 | Award | +134,615 | – | – | 1,437,937 |
| Martin Bonick President and CEO, Director | Apr 1, 2026 | Tax withholding | −10,952 | $8.67 | $94.95K | 1,303,322 |
| David Raynor Byers SVP & Chief Accounting Officer | Apr 1, 2026 | Award | +11,538 | – | – | 130,445 |
| David Raynor Byers SVP & Chief Accounting Officer | Apr 1, 2026 | Tax withholding | −924 | $8.67 | $8.01K | 118,907 |
| Edmondo Robinson Director | Apr 1, 2026 | Award | +14,231 | – | – | 58,215 |
| William M. Goodyear Director | Apr 1, 2026 | Award | +14,231 | – | – | 115,367 |
| Dave Caspers Chief Operating Officer | Apr 1, 2026 | Award | +35,673 | – | – | 71,277 |
| Dave Caspers Chief Operating Officer | Apr 1, 2026 | Tax withholding | −2,684 | $8.67 | $23.27K | 35,604 |
| Stephen C. Petrovich EVP, GC and Secretary | Apr 1, 2026 | Tax withholding | −1,808 | $8.67 | $15.68K | 749,803 |
| Stephen C. Petrovich EVP, GC and Secretary | Apr 1, 2026 | Award | +24,904 | – | – | 774,707 |
| Mark R. Sotir Director | Apr 1, 2026 | Award | +14,231 | – | – | 38,709 |
| Peter C. B. Bynoe Director | Apr 1, 2026 | Award | +14,231 | – | – | 115,367 |
| Suzanne Campion Director | Apr 1, 2026 | Award | +14,231 | – | – | 58,215 |
| Robert DeMichiei Director | Apr 1, 2026 | Award | +14,231 | – | – | 24,304 |
| Ellen Havdala Director | Apr 1, 2026 | Award | +14,231 | – | – | 115,367 |
| Robert Thomas Webb Director | Apr 1, 2026 | Award | +14,231 | – | – | 78,215 |
| Alfred Lumsdaine Chief Financial Officer | Apr 1, 2026 | Award | +53,846 | – | – | 319,183 |
| Alfred Lumsdaine Chief Financial Officer | Apr 1, 2026 | Tax withholding | −4,381 | $8.67 | $37.98K | 265,337 |
| Martin Bonick President and CEO, Director | Mar 31, 2026 | Tax withholding | −8,026 | $8.56 | $68.70K | 1,314,274 |
| David Raynor Byers SVP & Chief Accounting Officer | Mar 31, 2026 | Tax withholding | −819 | $8.56 | $7.01K | 119,831 |
| Stephen C. Petrovich EVP, GC and Secretary | Mar 31, 2026 | Tax withholding | −1,425 | $8.56 | $12.20K | 751,611 |
| Alfred Lumsdaine Chief Financial Officer | Mar 31, 2026 | Tax withholding | −2,510 | $8.56 | $21.49K | 269,718 |
| Alfred Lumsdaine Chief Financial Officer | Mar 11, 2026 | Award | +61,081 | – | – | 272,228 |
| Martin Bonick President and CEO, Director | Mar 11, 2026 | Award | +195,316 | – | – | 1,322,300 |
| Ethan Chernin President of Health Services | Mar 11, 2026 | Award | +32,408 | – | – | 68,396 |
| David Raynor Byers SVP & Chief Accounting Officer | Mar 11, 2026 | Award | +8,859 | – | – | 120,650 |
| Stephen C. Petrovich EVP, GC and Secretary | Mar 11, 2026 | Award | +34,733 | – | – | 753,036 |
| David Raynor Byers SVP & Chief Accounting Officer | Sep 25, 2025 | Tax withholding | −524 | $13.19 | $6.91K | 111,791 |
| Stephen C. Petrovich EVP, GC and Asst. Secretary | Sep 25, 2025 | Tax withholding | −788 | $13.19 | $10.39K | 718,303 |
| Alfred Lumsdaine Chief Financial Officer | Sep 25, 2025 | Tax withholding | −3,389 | $13.19 | $44.70K | 211,147 |
| Robert DeMichiei Director | Apr 2, 2025 | Award | +10,073 | – | – | 10,073 |
| Martin Bonick President and CEO, Director | Apr 1, 2025 | Award | +134,927 | – | – | 1,126,984 |
| Stephen C. Petrovich EVP, GC and Asst. Secretary | Apr 1, 2025 | Award | +22,263 | – | – | 719,091 |
| David Raynor Byers SVP & Chief Accounting Officer | Apr 1, 2025 | Award | +11,565 | – | – | 112,315 |
| Ethan Chernin President of Health Services | Apr 1, 2025 | Award | +20,914 | – | – | 35,988 |
| David Schultz President Hospital Operations | Apr 1, 2025 | Award | +26,985 | – | – | 64,172 |
| Dave Caspers Chief Operating Officer | Apr 1, 2025 | Award | +33,057 | – | – | 38,288 |
| Dave Caspers Chief Operating Officer | Apr 1, 2025 | Tax withholding | −2,480 | $12.97 | $32.17K | 5,231 |
| Dave Caspers Chief Operating Officer | Apr 1, 2025 | Award | +7,711 | – | – | 7,711 |
| Alfred Lumsdaine Chief Financial Officer | Apr 1, 2025 | Award | +53,971 | – | – | 214,536 |
| Martin Bonick President and CEO, Director | Mar 31, 2025 | Tax withholding | −12,970 | $13.75 | $178.34K | 992,057 |
| Stephen C. Petrovich EVP, GC and Asst. Secretary | Mar 31, 2025 | Tax withholding | −1,428 | $13.75 | $19.64K | 696,828 |
| David Raynor Byers SVP & Chief Accounting Officer | Mar 31, 2025 | Tax withholding | −676 | $13.75 | $9.30K | 100,750 |
| Ethan Chernin President of Health Services | Mar 31, 2025 | Tax withholding | −1,332 | $13.75 | $18.32K | 15,074 |
| David Schultz President Hospital Operations | Mar 31, 2025 | Tax withholding | −1,825 | $13.75 | $25.09K | 37,187 |
| Alfred Lumsdaine Chief Financial Officer | Mar 31, 2025 | Tax withholding | −2,510 | $13.75 | $34.51K | 160,565 |
| Peter C. B. Bynoe Director | Mar 21, 2025 | Award | +12,916 | – | – | 101,136 |
| William M. Goodyear Director | Mar 21, 2025 | Award | +12,916 | – | – | 101,136 |
| Edmondo Robinson Director | Mar 21, 2025 | Award | +12,916 | – | – | 43,984 |
| Rahul Sen Director | Mar 21, 2025 | Award | +12,916 | – | – | 24,478 |
| Suzanne Campion Director | Mar 21, 2025 | Award | +12,916 | – | – | 43,984 |
| Mark R. Sotir Director | Mar 21, 2025 | Award | +12,916 | – | – | 24,478 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Martin Bonick Former Officer & Director | Aug 27, 2026 | 35,930 | $398.03K | Aug 27, 2026 | Restricted Stock Vesting |
| Martin Bonick Former Officer & Director | Aug 25, 2026 | 35,930 | $401.36K | Aug 25, 2026 | Restricted Stock Vesting |
| Martin Bonick Former Officer & Director | Aug 20, 2026 | 35,930 | $377.36K | Aug 20, 2026 | Restricted Stock Vesting |
| Martin Bonick Former Officer & Director | Aug 18, 2026 | 35,930 | $393.48K | Aug 18, 2026 | Restricted Stock Vesting |